Recruiting
Mantle cell lymphoma
RecruitingInvestigational
Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma
Investigational
- Disease:Mantle cell lymphoma
- Substances:ZanubrutinibN-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Zanubrutinib












